Saikosaponin D: review on the antitumour effects, toxicity and pharmacokinetics

References

• Abe H, Sakaguchi M, Konishi H, Tani T, Arichi S. 1978. The effects of saikosaponins on biological membranes. 1. The relationship between the structures of saikosaponins and haemolytic activity. Planta Med. 34(2):160–166.
   PubMed Web of Science ®Google Scholar
• Ashour ML, Wink M. 2011. Genus Bupleurum: a review of its phytochemistry, pharmacology and modes of action. J Pharm Pharmacol. 63(3):305–321.
   PubMed Web of Science ®Google Scholar
• Bar-Zeev M, Livney YD, Assaraf YG. 2017. Targeted nanomedicine for cancer therapeutics: towards precision medicine overcoming drug resistance. Drug Resist Updat. 31:15–30.
   PubMed Web of Science ®Google Scholar
• Bu S, Xu J, Sun J. 2000. Effect of saikosaponin-D on up-regulating GR mRNA expression and inhibiting cell growth in human leukemia cells. Zhongguo Zhong Xi Yi Jie He Za Zhi. 20(5):350–352.
   PubMedGoogle Scholar
• Cai C, Zhang H, Ou Y, Jiang Y, Zhong D, Qi H, Dang Q. 2017. Saikosaponin-D suppresses cell growth in renal cell carcinoma through EGFR/p38 signaling pathway. Neoplasma. 64(4):518–525.
   PubMed Web of Science ®Google Scholar
• Chen L, Zhang F, Kong D, Zhu X, Chen W, Wang A, Zheng S. 2013. Saikosaponin D disrupts platelet-derived growth factor-β receptor/p38 pathway leading to mitochondrial apoptosis in human LO2 hepatocyte cells: a potential mechanism of hepatotoxicity. Chem Biol Interact. 206(1):76–82.
   PubMed Web of Science ®Google Scholar
• Cheng J, Fan XM. 2013. Role of cyclooxygenase-2 in gastric cancer development and progression. World J Gastroenterol. 19(42):7361–7368.
   PubMed Web of Science ®Google Scholar
• Cragg GM, Newman DJ. 2005. Plants as a source of anti-cancer agents. J Ethnopharmacol. 100(1–2):72–79.
   PubMed Web of Science ®Google Scholar
• Du JR, Long FY, Chen C. 2014. Research progress on natural triterpenoid saponins in the chemoprevention and chemotherapy of cancer. Enzymes. 36:95–130.
   PubMedGoogle Scholar
• Efferth T, Li PC, Konkimalla VS, Kaina B. 2007. From traditional Chinese medicine to rational cancer therapy. Trends Mol Med. 13(8):353–361.
   PubMed Web of Science ®Google Scholar
• Elmeliegy M, Vourvahis M, Guo C, Wang DD. 2020. Effect of p-glycoprotein (p-gp) inducers on exposure of p-gp substrates: review of clinical drug-drug interaction studies. Clin Pharmacokinet. 59(6):699–714.
   PubMed Web of Science ®Google Scholar
• Fu R, Zhang L, Li Y, Li B, Ming Y, Li Z, Xing H, Chen J. 2020. Saikosaponin D inhibits autophagosome-lysosome fusion and induces autophagy-independent apoptosis in MDA-MB-231 breast cancer cells. Mol Med Rep. 22(2):1026–1034.
   PubMed Web of Science ®Google Scholar
• Gao T, Zhao P, Yu X, Cao S, Zhang B, Dai M. 2019. Use of saikosaponin D and JNK inhibitor SP600125, alone or in combination, inhibits malignant properties of human osteosarcoma U2 cells. Am J Transl Res. 11(4):2070–2080.
   PubMed Web of Science ®Google Scholar
• Gezici S, Şekeroğlu N. 2019. Current perspectives in the application of medicinal plants against cancer: novel therapeutic agents. Anticancer Agents Med Chem. 19(1):101–111.
   PubMed Web of Science ®Google Scholar
• Giroux-Leprieur E, Costantini A, Ding VW, He B. 2018. Hedgehog signaling in lung cancer: from oncogenesis to cancer treatment resistance. IJMS. 19(9):2835.
   Google Scholar
• Guengerich FP, Waterman MR, Egli M. 2016. Recent structural insights into cytochrome P450 function. Trends Pharmacol Sci. 37(8):625–640.
   PubMed Web of Science ®Google Scholar
• Hashemi Goradel N, Najafi M, Salehi E, Farhood B, Mortezaee K. 2019. Cyclooxygenase-2 in cancer: a review. J Cell Physiol. 234(5):5683–5699.
   PubMed Web of Science ®Google Scholar
• He S, Lu G, Hou H, Zhao Z, Zhu Z, Lu X, Chen J, Wang Z. 2014. Saikosaponin-D suppresses the expression of cyclooxygenase-2 through the phospho-signal transducer and activator of transcription 3/hypoxia-inducible factor-1α pathway in hepatocellular carcinoma cells. Mol Med Rep. 10(5):2556–2562.
   PubMed Web of Science ®Google Scholar
• He Y, Hu Z, Li A, Zhu Z, Yang N, Ying Z, He J, Wang C, Yin S, Cheng S. 2019. Recent advances in biotransformation of saponins. Molecules. 24:2365.
   PubMed Web of Science ®Google Scholar
• Hsu YL, Kuo PL, Chiang LC, Lin CC. 2004. Involvement of p53, nuclear factor kappaB and Fas/Fas ligand in induction of apoptosis and cell cycle arrest by saikosaponin D in human hepatoma cell lines. Cancer Lett. 213(2):213–221.
   PubMed Web of Science ®Google Scholar
• Hsu YL, Kuo PL, Lin CC. 2004. the proliferative inhibition and apoptotic mechanism of saikosaponin D in human non-small cell lung cancer A549 cells. Life Sci. 75(10):1231–1242.
   PubMed Web of Science ®Google Scholar
• Hu SC, Lai YC, Lin CL, Tzeng WS, Yen FL. 2019. Inclusion complex of saikosaponin-D with hydroxypropyl-β-cyclodextrin: improved physicochemical properties and anti-skin cancer activity. Phytomedicine. 57:174–182.
   PubMed Web of Science ®Google Scholar
• Hu SC, Lee IT, Yen MH, Lin CC, Lee CW, Yen FL. 2016. Anti-melanoma activity of Bupleurum chinense, Bupleurum kaoi and nanoparticle formulation of their major bioactive compound saikosaponin-D. J Ethnopharmacol. 179:432–442.
   PubMed Web of Science ®Google Scholar
• Huang W, Sun R. 2010. Study on hepatotoxicity on rats caused by crude extracts of total saikosaponins and correlation with oxidative damage mechanism. Zhongguo Zhong Yao Za Zhi. 35:1745–1749.
   PubMedGoogle Scholar
• Hussain S, Singh A, Nazir SU, Tulsyan S, Khan A, Kumar R, Bashir N, Tanwar P, Mehrotra R. 2019. Cancer drug resistance: a fleet to conquer. J Cell Biochem. 120(9):14213–14225.
   PubMed Web of Science ®Google Scholar
• Ikegami F, Fujii Y, Ishihara K, Satoh T. 2003. Toxicological aspects of Kampo medicines in clinical use. Chem Biol Interact. 145(3):235–250.
   PubMed Web of Science ®Google Scholar
• Jiang H, Yang L, Hou A, Zhang J, Wang S, Man W, Zheng S, Yu H, Wang X, Yang B, et al. 2020. Botany, traditional uses, phytochemistry, analytical methods, processing, pharmacology and pharmacokinetics of Bupleuri Radix: a systematic review. Biomed Pharmacother. 131:110679.
   PubMed Web of Science ®Google Scholar
• Katz OB, Shaked Y. 2015. Host effects contributing to cancer therapy resistance. Drug Resist Updat. 19:33–42.
   PubMed Web of Science ®Google Scholar
• Kiess TO, Kockskämper J. 2019. SERCA activity controls the systolic calcium increase in the nucleus of cardiac myocytes. Front Physiol. 10:56.
   PubMed Web of Science ®Google Scholar
• King FW, Fong S, Griffin C, Shoemaker M, Staub R, Zhang YL, Cohen I, Shtivelman E. 2009. Timosaponin AIII is preferentially cytotoxic to tumor cells through inhibition of mTOR and induction of ER stress. PLoS One. 4(9):e7283.
   PubMed Web of Science ®Google Scholar
• Kirtane AR, Kalscheuer SM, Panyam J. 2013. Exploiting nanotechnology to overcome tumor drug resistance: challenges and opportunities. Adv Drug Deliv Rev. 65(13–14):1731–1747.
   PubMed Web of Science ®Google Scholar
• Lai M, Ge Y, Chen M, Sun S, Chen J, Cheng R. 2020. Saikosaponin D inhibits proliferation and promotes apoptosis through activation of MKK4-JNK signaling pathway in pancreatic cancer cells. Onco Targets Ther. 13:9465–9479.
   PubMed Web of Science ®Google Scholar
• Li C, Guan X, Xue H, Wang P, Wang M, Gai X. 2017. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells. Pathol Res Pract. 213(7):848–853.
   PubMed Web of Science ®Google Scholar
• Li C, Xue HG, Feng LJ, Wang ML, Wang P, Gai XD. 2017. The effect of saikosaponin D on doxorubicin pharmacokinetics and its MDR reversal in MCF-7/adr cell xenografts. Eur Rev Med Pharmacol Sci. 21(19):4437–4445.
   PubMed Web of Science ®Google Scholar
• Li DQ, Wu J, Liu LY, Wu YY, Li LZ, Huang XX, Liu QB, Yang JY, Song SJ, Wu CF. 2015. Cytotoxic triterpenoid glycosides (saikosaponins) from the roots of Bupleurum chinense. Bioorg Med Chem Lett. 25(18):3887–3892.
   PubMed Web of Science ®Google Scholar
• Li H, Tang Y, Wang Y, Wei W, Yin C, Tang F. 2020. Effects of saikosaponin D on CYP1A2 and CYP2D6 in HepaRG Cells. Drug Des Devel Ther. 14:5251–5258.
   PubMed Web of Science ®Google Scholar
• Li H, Tang Y, Wei W, Yin C, Tang F. 2021. Effects of saikosaponin-D on CYP3A4 in HepaRG cell and protein-ligand docking study. Basic Clin Pharmacol Toxicol. 128(5):661–668.
   PubMed Web of Science ®Google Scholar
• Li X, Li X, Huang N, Liu R, Sun R. 2018. A comprehensive review and perspectives on pharmacology and toxicology of saikosaponins. Phytomedicine. 50:73–87.
   PubMed Web of Science ®Google Scholar
• Li Y, Cai T, Zhang W, Zhu W, Lv S. 2017. Effects of saikosaponin D on apoptosis in human U87 glioblastoma cells. Mol Med Rep. 16(2):1459–1464.
   PubMed Web of Science ®Google Scholar
• Lin HJ, Kao ST, Siao YM, Yeh CC. 2015. The Chinese medicine Sini-San inhibits HBx-induced migration and invasiveness of human hepatocellular carcinoma cells. BMC Complement Altern Med. 15:348.
   PubMed Web of Science ®Google Scholar
• Liu J, Xue Y, Sun J, Fu R, Ren S, Zhang Z, Song R. 2019. Pharmacokinetics and oral bioavailability studies of three saikogenins in rats using a validated UFLC-MS/MS method. J Chromatogr B Analyt Technol Biomed Life Sci. 1124:265–272.
   PubMed Web of Science ®Google Scholar
• Liu RY, Li JP. 2014. Saikosaponin-D inhibits proliferation of human undifferentiated thyroid carcinoma cells through induction of apoptosis and cell cycle arrest. Eur Rev Med Pharmacol Sci. 18(17):2435–2443.
   PubMed Web of Science ®Google Scholar
• Lorent JH, Quetin-Leclercq J, Mingeot-Leclercq MP. 2014. The amphiphilic nature of saponins and their effects on artificial and biological membranes and potential consequences for red blood and cancer cells. Org Biomol Chem. 12(44):8803–8822.
   PubMed Web of Science ®Google Scholar
• Lv L, Huang W, Yu X, Ren H, Sun R. 2009. Comparative research of different Bupleurum chinense composition to influence of hepatotoxicity of rats and oxidative damage mechanism. Zhongguo Zhong Yao Za Zhi. 34(18):2364–2368.
   PubMedGoogle Scholar
• Mahboubi Rabbani SMI, Zarghi A. 2019. Selective COX-2 inhibitors as anticancer agents: a patent review (2014-2018). Expert Opin Ther Pat. 29(6):407–427.
   PubMed Web of Science ®Google Scholar
• Maik-Rachline G, Lifshits L, Seger R. 2020. Nuclear p38: roles in physiological and pathological processes and regulation of nuclear translocation. IJMS. 21(17):6102.
   Google Scholar
• Martínez-Limón A, Joaquin M, Caballero M, Posas F, de Nadal E. 2020. The p38 pathway: from biology to cancer therapy. IJMS. 21(6):1913.
   Google Scholar
• Meng J, Yao R, Chen X, Yang X, Li Z. 2012. Advances in studies on classification of Bupleurum. Zhongguo Zhong Yao Za Zhi. 37(11):1523–1526.
   PubMedGoogle Scholar
• Meselhy M. 1999. Human intestinal bacteria responsible for the metabolism of saikosaponins. J Trandition Med. 17:1–11.
   Google Scholar
• Möbius C, Stein HJ, Spiess C, Becker I, Feith M, Theisen J, Gais P, Jütting U, Siewert JR. 2005. COX2 expression, angiogenesis, proliferation and survival in Barrett's cancer. Eur J Surg Oncol. 31(7):755–759.
   PubMed Web of Science ®Google Scholar
• Mollinedo F, Gajate C. 2020. Lipid rafts as signaling hubs in cancer cell survival/death and invasion: implications in tumor progression and therapy: thematic review series: biology of lipid rafts. J Lipid Res. 61(5):611–635.
   PubMed Web of Science ®Google Scholar
• Nose M, Amagaya S, Ogihara Y. 1989. Effects of saikosaponin metabolites on the hemolysis of red blood cells and their adsorbability on the cell membrane. Chem Pharm Bull (Tokyo)). 37(12):3306–3310.
   PubMed Web of Science ®Google Scholar
• Platanias LC. 2003. The p38 mitogen-activated protein kinase pathway and its role in interferon signaling. Pharmacol Ther. 98(2):129–142.
   PubMed Web of Science ®Google Scholar
• Prueksaritanont T, Chu X, Gibson C, Cui D, Yee KL, Ballard J, Cabalu T, Hochman J. 2013. Drug-drug interaction studies: regulatory guidance and an industry perspective. Aaps J. 15(3):629–645.
   PubMed Web of Science ®Google Scholar
• Qin T, Fu X, Yu J, Zhang R, Deng X, Fu Q, Ma Z, Ma S. 2019. Modification of GSK3β/β-catenin signaling on saikosaponins-D-induced inhibition of neural progenitor cell proliferation and adult neurogenesis. Toxicology. 424:152233.
   PubMed Web of Science ®Google Scholar
• Qin T, Yuan Z, Yu J, Fu X, Deng X, Fu Q, Ma Z, Ma S. 2020. Saikosaponin-D impedes hippocampal neurogenesis and causes cognitive deficits by inhibiting the survival of neural stem/progenitor cells via neurotrophin receptor signaling in mice. Clin Transl Med. 10(8):e243.
   PubMed Web of Science ®Google Scholar
• Ren M, McGowan E, Li Y, Zhu X, Lu X, Zhu Z, Lin Y, He S. 2019. Saikosaponin-D suppresses COX2 through p-STAT3/C/EBPβ signaling pathway in liver cancer: a novel mechanism of action. Front Pharmacol. 10:623.
   PubMed Web of Science ®Google Scholar
• Sanchez-Prieto R, Rojas JM, Taya Y, Gutkind JS. 2000. A role for the p38 mitogen-acitvated protein kinase pathway in the transcriptional activation of p53 on genotoxic stress by chemotherapeutic agents. Cancer Res. 60(9):2464–2472.
   PubMed Web of Science ®Google Scholar
• Shaheen U, Ragab EA, Abdalla AN, Bader A. 2018. Triterpenoidal saponins from the fruits of Gleditsia caspica with proapoptotic properties. Phytochemistry. 145:168–178.
   PubMed Web of Science ®Google Scholar
• Shimizu K, Amagaya S, Ogihara Y. 1985. Structural transformation of saikosaponins by gastric juice and intestinal flora. J Pharmacobiodyn. 8(9):718–725.
   PubMedGoogle Scholar
• Tang C, Fu Q, Chen X, Hu Y, Renaud H, Ma C, Rao T, Chen Y, Tan Z, Klaassen CD, et al. 2020. The biotransformation of Bupleuri Radix by human gut microbiota. Xenobiotica. 50(9):1011–1022.
   PubMed Web of Science ®Google Scholar
• Tang JC, Long F, Zhao J, Hang J, Ren YG, Chen JY, Mu B. 2019. The effects and mechanisms by which saikosaponin-D enhances the sensitivity of human non-small cell lung cancer cells to gefitinib. J Cancer. 10(26):6666–6672.
   PubMed Web of Science ®Google Scholar
• Tian YD, Lin S, Yang PT, Bai MH, Jin YY, Min WL, Ma HB, Wang BF. 2019. Saikosaponin-D increases the radiosensitivity of hepatoma cells by adjusting cell autophagy. J Cancer. 10(20):4947–4953.
   PubMed Web of Science ®Google Scholar
• Trempolec N, Dave-Coll N, Nebreda AR. 2013. Snapshot: p38 MAPK substrates. Cell. 152(4):924–924.e921.
   PubMedGoogle Scholar
• Tsai YJ, Chen IL, Horng LY, Wu RT. 2002. Induction of differentiation in rat C6 glioma cells with saikosaponins. Phytother Res. 16(2):117–121.
   PubMed Web of Science ®Google Scholar
• Tsuyoshi H, Wong VKW, Han Y, Orisaka M, Yoshida Y, Tsang BK. 2017. Saikosaponin-D, a calcium mobilizing agent, sensitizes chemoresistant ovarian cancer cells to cisplatin-induced apoptosis by facilitating mitochondrial fission and G2/M arrest. Oncotarget. 8(59):99825–99840.
   PubMedGoogle Scholar
• Waheed A, Barker J, Barton SJ, Owen CP, Ahmed S, Carew MA. 2012. A novel steroidal saponin glycoside from Fagonia indica induces cell-selective apoptosis or necrosis in cancer cells. Eur J Pharm Sci. 47(2):464–473.
   PubMed Web of Science ®Google Scholar
• Wang BF, Dai ZJ, Wang XJ, Bai MH, Lin S, Ma HB, Wang YL, Song LQ, Ma XL, Zan Y, et al. 2013. Saikosaponin-D increases the radiosensitivity of SMMC-7721 hepatocellular carcinoma cells by adjusting the G0/G1 and G2/M checkpoints of the cell cycle. BMC Complement Altern Med. 13:263.
   PubMed Web of Science ®Google Scholar
• Wang BF, Lin S, Bai MH, Song LQ, Min WL, Wang M, Yang P, Ma HB, Wang XJ. 2014. Effects of SSD combined with radiation on inhibiting SMMC-7721 hepatoma cell growth. Med Sci Monit. 20:1340–1344.
   PubMed Web of Science ®Google Scholar
• Wang J, Qi H, Zhang X, Si W, Xu F, Hou T, Zhou H, Wang A, Li G, Liu Y, et al. 2018. Saikosaponin D from Radix Bupleuri suppresses triple-negative breast cancer cell growth by targeting β-catenin signaling . Biomed Pharmacother. 108:724–733.
   PubMed Web of Science ®Google Scholar
• Wang P, Ren J, Tang J, Zhang D, Li B, Li Y. 2010. Estrogen-like activities of saikosaponin-D in vitro: a pilot study. Eur J Pharmacol. 626(2–3):159–165.
   PubMed Web of Science ®Google Scholar
• Wang Q, Zheng X, Yang L, Shi F, Gao L, Zhong Y, Sun H, He F, Lin Y, Wang X. 2010. Reactive oxygen species-mediated apoptosis contributes to chemosensitization effect of saikosaponins on cisplatin-induced cytotoxicity in cancer cells. J Exp Clin Cancer Res. 29:159.
   PubMed Web of Science ®Google Scholar
• Wang S, Zhang Y, Zhang Q, Peng S, Shen C, Yu Y, Zhang M, Yang W, Wu Q, Zhang Y, et al. 2017. Content decline of SERCA inhibitors saikosaponin A and D attenuates cardiotoxicity and hepatotoxicity of vinegar-baked Radix bupleuri. Environ Toxicol Pharmacol. 52:129–137.
   PubMed Web of Science ®Google Scholar
• Wong VK, Li T, Law BY, Ma ED, Yip NC, Michelangeli F, Law CK, Zhang MM, Lam KY, Chan PL, et al. 2013. Saikosaponin-D, a novel SERCA inhibitor, induces autophagic cell death in apoptosis-defective cells. Cell Death Dis. 4:e720.
   PubMed Web of Science ®Google Scholar
• Wong VK, Zhang MM, Zhou H, Lam KY, Chan PL, Law CK, Yue PY, Liu L2. 2013. Saikosaponin-D enhances the anticancer potency of TNF-α via overcoming its undesirable response of activating NF-Kappa B signalling in cancer cells. Evid Based Complement Alternat Med. 2013:745295.
   PubMed Web of Science ®Google Scholar
• Wu S, Chen W, Liu K, Ren F, Zheng D, Xu F, Wu H. 2020. Saikosaponin D inhibits proliferation and induces apoptosis of non-small cell lung cancer cells by inhibiting the STAT3 pathway. J Int Med Res. 48(9):300060520937163.
   PubMed Web of Science ®Google Scholar
• Xiao K, Li K, Long S, Kong C, Zhu S. 2020. Potential molecular mechanisms of Chaihu-Shugan-San in treatment of breast cancer based on network pharmacology. Evid Based Complement Alternat Med. 2020:3670309.
   PubMedGoogle Scholar
• Xu L, Ji Z, Guo L, Zhang R, Qu R, Ma S. 2018. Saikosaponin-D-mediated downregulation of neurogenesis results in cognitive dysfunction by inhibiting Akt/Foxg-1 pathway in mice. Toxicol Lett. 284:79–85.
   PubMed Web of Science ®Google Scholar
• Xu L, Song R, Tian JX, Tian Y, Liu GQ, Zhang ZJ. 2012. Analysis of saikosaponins in rat plasma by anionic adducts-based liquid chromatography tandem mass spectrometry method. Biomed Chromatogr. 26(7):808–815.
   PubMed Web of Science ®Google Scholar
• Yao M, Yang J, Cao L, Zhang L, Qu S, Gao H. 2014. Saikosaponin-D inhibits proliferation of DU145 human prostate cancer cells by inducing apoptosis and arresting the cell cycle at G0/G1 phase. Mol Med Rep. 10(1):365–372.
   PubMed Web of Science ®Google Scholar
• Yokota T, Wang Y. 2016. p38 MAP kinases in the heart. Gene. 575(2 Pt 2):369–376.
   PubMed Web of Science ®Google Scholar
• Yu P, Qiu H, Wang M, Tian Y, Zhang Z, Song R. 2017. In vitro metabolism study of saikosaponin D and its derivatives in rat liver microsomes. Xenobiotica. 47(1):11–19.
   PubMed Web of Science ®Google Scholar
• Yuan B, Yang R, Ma Y, Zhou S, Zhang X, Liu Y. 2017. A systematic review of the active saikosaponins and extracts isolated from Radix Bupleuri and their applications. Pharm Biol. 55(1):620–635.
   PubMed Web of Science ®Google Scholar
• Zhang CY, Jiang ZM, Ma XF, Li Y, Liu XZ, Li LL, Wu WH, Wang T. 2019. Saikosaponin-D inhibits the hepatoma cells and enhances chemosensitivity through SENP5-dependent inhibition of Gli1 SUMOylation under hypoxia. Front Pharmacol. 10:1039.
   PubMed Web of Science ®Google Scholar
• Zhang F, Chen L, Jin H, Shao J, Wu L, Lu Y, Zheng S. 2016. Activation of Fas death receptor pathway and Bid in hepatocytes is involved in saikosaponin D induction of hepatotoxicity. Environ Toxicol Pharmacol. 41:8–13.
   PubMed Web of Science ®Google Scholar
• Zhang G, Jin B, Li YP. 2011. C/EBPβ mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wasting. Embo J. 30(20):4323–4335.
   PubMed Web of Science ®Google Scholar
• Zhao L, Li J, Sun ZB, Sun C, Yu ZH, Guo X. 2019. Saikosaponin D inhibits proliferation of human osteosarcoma cells via the p53 signaling pathway. Exp Ther Med. 17(1):488–494.
   PubMed Web of Science ®Google Scholar
• Zheng J, Chen J, Zou X, Zhao F, Guo M, Wang H, Zhang T, Zhang C, Feng W, Pessah IN, et al. 2019. Saikosaponin D causes apoptotic death of cultured neocortical neurons by increasing membrane permeability and elevating intracellular Ca2+ concentration. Neurotoxicology. 70:112–121.
   PubMed Web of Science ®Google Scholar
• Zhong D, Zhang HJ, Jiang YD, Wu P, Qi H, Cai C, Zheng SB, Dang Q. 2016. Saikosaponin-D: A potential chemotherapeutics in castration resistant prostate cancer by suppressing cancer metastases and cancer stem cell phenotypes. Biochem Biophys Res Commun. 474(4):722–729.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Shi C, Zeng L, Liu G, Jiang W, Zhang X, Chen S, Guo J, Jian X, Ouyang J, et al. 2020. High COX-2 expression in cancer-associated fibiroblasts contributes to poor survival and promotes migration and invasiveness in nasopharyngeal carcinoma. Mol Carcinog. 59(3):265–280.
   PubMed Web of Science ®Google Scholar